Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

NCT: NCT06376734 · RECRUITING

NCT IDNCT06376734
StatusRECRUITING
Start Date2025-01-30
Completion2030-06-01
SponsorBrigham and Women's Hospital (OTHER)
First posted
Last updated

Brief Summary

Participants will receive Transcranial Magnetic Stimulation (TMS) at a random location in the left prefrontal cortex, excluding sites that are potentially unsafe. Extensive behavioral testing will be conducted to determine which behaviors are modulated by stimulating which circuits.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑